Patent: 10,184,121
✉ Email this page to a colleague
Summary for Patent: 10,184,121
Title: | Methods for removing viral contaminants from pancreatic extracts |
Abstract: | Methods for screening pancrelipase for RNA virus contamination comprise removing free viral RNA from the pancrelipase, denaturing any viruses in the pancrelipase to release encapsidated RNA into the pancrelipase milieu, and detecting this released RNA. Removal of free viral RNA may comprise treating pancrelipase with RNase and DNase or precipitating the protein fraction of pancrelipase with a salt that precipitates the protein fraction while leaving nucleic acids such as RNA in solution. Pancrelipase substantially devoid of free nucleic acid is also provided. |
Inventor(s): | Ortenzi; Giovanni (Monza, IT), Ghidorsi; Luigi (Milan, IT) |
Assignee: | ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (Dublin, IE) |
Application Number: | 14/744,447 |
Patent Claims: | see list of patent claims |
Details for Patent 10,184,121
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | COTAZYM | pancrelipase | Capsule, Delayed Release | 020580 | 12/09/1996 | ⤷ Try a Trial | 2034-06-19 |
Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 04/30/2009 | ⤷ Try a Trial | 2034-06-19 |
Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 06/10/2011 | ⤷ Try a Trial | 2034-06-19 |
Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 03/14/2013 | ⤷ Try a Trial | 2034-06-19 |
Digestive Care, Inc. | PERTZYE | pancrelipase | Capsule, Delayed Release | 022175 | 05/17/2012 | ⤷ Try a Trial | 2034-06-19 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |